Susanne Arnold

Closed portfolio with an early-phase archive tilt

According to ClinicalTrials.gov-derived indexes, Susanne Arnold sits in the upper quartile of US sponsors by registered trial count (#1,604 of 15,742 sponsors by registered trial count).

8 total trials none currently recruiting 4 completed early-phase tilt upper quartile by trial count

Susanne Arnold: 8 sponsored US clinical trials, none currently recruiting.

Susanne Arnold sponsors 8 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 4 completed. 0 of these trials are in Phase 3-4 (later-stage) and 6 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Stage IIIB Non-small Cell Lung Cancer, with 1 trials.

Upper-quartile sponsor footprint

Susanne Arnold sits in the upper quartile of the sponsor corpus (#1,604 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.

Indexed trials (enrollment closed)

8 total, page 1 of 1

ACTIVE NOT RECRUITING Phase 2

Cisplatin + Radiation in SCCHN and Correlation With Oxidative Stress Markers

NCT02994069
TERMINATED Phase 2

Novel Agents for Treatment of High-risk COVID-19 Positive Patients

NCT04374019
COMPLETED Phase 2

A Study of Chemo +/- Low-dose Radiation as Induction Therapy in SCCHN

NCT02126969
COMPLETED

Study of Lung Cancer in Appalachian Kentucky: The Role of Environmental Carcinogens

NCT01648166
TERMINATED Phase 1

Phase I Trial of Biweekly Gemcitabine & Paclitaxel & Low-Dose Radiation for Metastatic or Recurrent Head & Neck Cancer

NCT00176241
COMPLETED Phase 2

Effects of Carboplatin and Gemcitabine on Stage IIIB Pleural Effusion and Stage IV Lung Cancer

NCT00247416
COMPLETED NA

Early Detection of Lung Cancer in a High-Risk Population Defined by PFT, Biomarkers, and CT Scanning

NCT00596310
TERMINATED Phase 1

Phase I Trial of Docetaxel and Low-Dose Fractionated Radiation in the Treatment of Metastatic or Recurrent NSCLC

NCT00378404

Phase Distribution

PhaseTrial count
Phase 1 2
Phase 2 4

Therapeutic Areas

Stage IIIB Non-small Cell Lung Cancer 1
Stage IV Non-small Cell Lung Cancer 1
Carcinoma, Squamous Cell 1
Lung Cancer 1
Head and Neck Cancer 1

How the Susanne Arnold early-phase archive is shaped

8 indexed studies, none listed as recruiting (0% open); 4 completed (50%).

Phase mix: 0 late (III/IV) vs 6 early (I/II) (early-phase heavy).

Top condition: Stage IIIB Non-small Cell Lung Cancer (1 trial), 4 others listed.

How to read a closed sponsor archive

When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.

Susanne Arnold: archived-pipeline peers nationwide

Peers matched on 8 indexed studies with no current recruiting: volume and archive shape, not condition overlap.

Susanne Arnold sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 051015 0%10%20%30%40% Total trials Recruiting share Susanne ArnoldAB ScienceAbbott Point of CareAbeona TherapeuticsAcademisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)10xBio22nd Century Group23andMe3-C Institute for Social Development
Susanne Arnold sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Susanne Arnold sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 8 archived trials

Sponsors with similar archive density (± trial count)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Susanne Arnold page

8 registered trials is a research-attention snapshot, not an endorsement of Susanne Arnold or any single study.

  • None of Susanne Arnold's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
  • Stage IIIB Non-small Cell Lung Cancer is the condition Susanne Arnold studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Stage IIIB Non-small Cell Lung Cancer trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Susanne Arnold pipeline card: 8 registered trials from official public datasets.Report a data error.